Drug Trial Radar · NCT00688857
Open-label Pharmacokinetic Study of Diazoxide Choline Coated vs. Uncoated Formulations
Last checked: Nov 19, 2026Latest source record: Nov 8, 2010 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
12
Planned (sponsor's estimate)
Start
May 2008
Primary completion
Jun 2008
Study completion Jul 2008
Sponsor
- Lead sponsor
- Essentialis, Inc.Industry
- Sponsor type
- Industry
- Collaborators
- Cetero Research, San Antonio
- First posted
- Jun 3, 2008
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Crossover
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This is a single-center, randomized, open-label, multi-dose crossover study assessing the pharmacokinetic profiles of diazoxide choline coated versus uncoated formulations in healthy volunteers. The primary objective is to compare the pharmacokinetic (PK) profiles of diazoxide choline controlled-release coated tablets versus uncoated tablets in healthy volunteers under fed conditions. Secondary objectives are to assess diazoxide choline pharmacokinetic (PK) parameters under fasted conditions, and to assess the safety and tolerability of diazoxide choline controlled-release coated tablets versus uncoated tablets in healthy volunteers.
Conditions
- Hypertriglyceridemia
Interventions
Diazoxide cholineDrug
Diazoxide choline controlled-release coated tablets versus Diazoxide choline controlled-release uncoated tablets administered orally once daily
Diazoxide cholineDrug
Diazoxide choline controlled-release uncoated tablets versus Diazoxide choline controlled-release coated tablets administered orally once daily
Primary outcomes
What the sponsor says the trial is designed to measure.
- Compare the pharmacokinetic (PK) profiles of diazoxide choline controlled-release coated tablets versus uncoated tablets in healthy volunteers under fed conditions.Time frame: 16 days
Locations
1 site in 1 country. Site status is shown where the registry gives one.
PRACS Institute, Ltd. - Cetero Research
Fargo, North Dakota
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.